Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
Division of Vascular Surgery, Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland.
JAMA Surg. 2015 Jun;150(6):529-36. doi: 10.1001/jamasurg.2015.0287.
Superior outcomes have been established with the use of an arteriovenous fistula (AVF) at first hemodialysis. However, considering the influence of comorbidities, medical insurance, and specialist care, racial/ethnic differences in the patterns of utilization of AVFs are unknown and deserve evaluation.
To assess national trends in initial hemodialysis access with respect to race/ethnicity stratified by comorbid disease, nephrology care, and medical insurance status within the US Renal Data System.
DESIGN, SETTING, AND PARTICIPANTS: A retrospective analysis of all patients with end-stage renal disease in the US Renal Data System who initiated hemodialysis between January 1, 2006, and December 31, 2010. Univariable statistics (χ² test and analysis of variance) and logistic regression were used to compare racial/ethnic groups (white vs black vs Hispanic). Multivariable logistic regression and propensity score-matching techniques were used to evaluate hemodialysis access rates between patients of different races/ethnicities with comparable characteristics.
Utilization rates of AVF, arteriovenous graft, and intravascular hemodialysis catheter.
In this cohort of 396,075 patients, more white patients initiated hemodialysis with an AVF than black patients or Hispanic patients (18.3% vs 15.5% and 14.6%, respectively; P < .001). Black patients and Hispanic patients initiated hemodialysis with an AVF less frequently despite being younger and having less coronary artery disease, chronic obstructive pulmonary disease, and cancer than white patients with an AVF. When stratified by medical insurance status, black patients (odds ratios, 0.90 [95% CI, 0.82-0.98] for uninsured and 0.85 [95% CI, 0.84-0.87] for insured) and Hispanic patients (odds ratios, 0.72 [95% CI, 0.65-0.81] for uninsured and 0.81 [95% CI, 0.79-0.84] for insured) persistently initiated hemodialysis with an AVF less frequently than white patients (P < .05 for all). Arteriovenous fistula utilization at initial hemodialysis was lower among black patients (odds ratio, 0.81 [95% CI, 0.78-0.84]) and Hispanic patients (odds ratio, 0.86 [95% CI, 0.82-0.90]) compared with white patients within the category of patients who had nephrology care for longer than 1 year (P < .001 for all).
Black patients and Hispanic patients tend to initiate hemodialysis with an AVF less frequently than white patients despite being younger and having fewer comorbidities. These disparities persisted independent of factors that drive health access for fistula placement, such as medical insurance status and nephrology care. The sociocultural underpinnings of these disparities deserve investigation and redress to maximize the benefits of initiating hemodialysis via fistula in patients with end-stage renal disease irrespective of race/ethnicity.
在首次血液透析中使用动静脉瘘 (AVF) 已被证实可获得更好的结果。然而,考虑到合并症、医疗保险和专科护理的影响,不同种族/民族在 AVF 利用模式上的差异尚不清楚,值得评估。
在美国肾脏数据系统 (US Renal Data System) 中,评估根据合并症、肾脏病护理和医疗保险状况分层的初始血液透析通路的全国趋势。
设计、设置和参与者:这是一项对美国肾脏数据系统中所有 2006 年 1 月 1 日至 2010 年 12 月 31 日期间开始血液透析的终末期肾病患者的回顾性分析。使用单变量统计(χ²检验和方差分析)和逻辑回归比较了不同种族/民族(白人、黑人、西班牙裔)之间的差异。使用多变量逻辑回归和倾向评分匹配技术评估不同种族/民族之间具有相似特征的患者的血液透析通路使用率。
动静脉瘘、动静脉移植物和血管内血液透析导管的使用情况。
在这 396075 名患者队列中,与黑人患者或西班牙裔患者相比,更多的白人患者开始接受动静脉瘘血液透析(分别为 18.3%、15.5%和 14.6%;P<0.001)。尽管黑人患者和西班牙裔患者比白人患者年轻,且患有较少的冠状动脉疾病、慢性阻塞性肺疾病和癌症,但他们开始接受动静脉瘘血液透析的频率较低。按医疗保险状况分层时,黑人患者(比值比,0.90 [95%CI,0.82-0.98] 为未参保和 0.85 [95%CI,0.84-0.87] 为参保)和西班牙裔患者(比值比,0.72 [95%CI,0.65-0.81] 为未参保和 0.81 [95%CI,0.79-0.84] 为参保)开始接受动静脉瘘血液透析的频率明显低于白人患者(所有 P<0.05)。与白人患者相比,黑人患者(比值比,0.81 [95%CI,0.78-0.84])和西班牙裔患者(比值比,0.86 [95%CI,0.82-0.90])在接受肾脏病护理超过 1 年的患者中,动静脉瘘的使用率较低(所有 P<0.001)。
尽管黑人患者和西班牙裔患者比白人患者年轻,且患有较少的合并症,但他们开始接受动静脉瘘血液透析的频率较低。这些差异在医疗保险状况和肾脏病护理等影响通路获取的因素之外仍然存在。这些差异的社会文化基础值得调查和纠正,以最大限度地提高终末期肾病患者通过瘘管开始血液透析的益处,无论其种族/民族如何。